Meghmani Organics working capital

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
155.17×155.17×161.18×208.51×156.14×
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
104.00×104.00×87.72×111.42×76.23×
150.09×150.09×150.75×167.91×123.59×
109.08×109.08×98.15×152.02×108.78×
23.72×24.52×14.19×9.98×5.86×
0.71×0.71×0.68×0.50×0.85×
7.72×7.72×−6.25×−2.35×0.86×
1.26×1.26×0.46×−12.31×0.60×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MOL₹51.99

Meghmani Organics Limited

· Chemicals
₹ CrorePeersIPLPUNJABCHEMINSECTICIDASTECBHARATRASDHARMAJGSPCROPADVANCEMcap ₹1,322 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)156.14208.51161.18155.17155.17
Receivable Days (DSO)76.23111.4287.72104.00104.00
Payable Days (DPO)123.59167.91150.75150.09150.09
Cash Conversion Cycle (days)108.78152.0298.15109.08109.08
Working Capital Turnover5.869.9814.1924.5223.72
Asset Turnover0.850.500.680.710.71
Cash Conversion (CFO/Net Income)0.86-2.35-6.257.727.72
CFO/EBITDA0.60-12.310.461.261.26
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.